Position in JNJ
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$5,430,894
+$205,256 QoQ
Shares Held
21,384
+0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.42%
of 13F equity value
Holder Rank
#1,563
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Beaton Management Co. Inc. holds $24,228,910 across 8 Drug Manufacturers - General names. JNJ ranks #2 (22.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,856 | $7,023,862 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
21,384 | $5,430,894 | |
| 3 | ABBV |
AbbVie Inc.
|
15,542 | $3,910,988 | |
| 4 | MRK |
Merck & Co., Inc.
|
21,587 | $2,773,929 | |
| 5 | NVS |
Novartis AG
|
8,873 | $1,390,576 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
23,369 | $1,346,521 | |
| 7 | AMGN |
Amgen Inc
|
3,409 | $1,234,467 | |
| 8 | PFE |
Pfizer Inc
|
46,415 | $1,117,673 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,430,894 | 21,384 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $5,225,638 | 21,378 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $4,427,074 | 21,392 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $3,994,317 | 21,542 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,290,540 | 21,542 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,619,789 | 21,827 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $3,171,082 | 21,927 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $3,587,036 | 22,134 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $3,235,105 | 22,134 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $3,500,270 | 22,127 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $3,477,120 | 22,184 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $3,455,158 | 22,184 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $3,707,482 | 22,399 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $3,472,930 | 22,406 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,965,085 | 22,446 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,666,778 | 22,446 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,933,621 | 22,160 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,927,416 | 22,160 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,806,307 | 22,250 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $3,583,685 | 22,190 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $3,663,817 | 22,240 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $3,655,144 | 22,240 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $3,543,410 | 22,515 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $3,387,764 | 22,755 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,357,541 | 23,875 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $3,124,172 | 23,825 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||